ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mr. Mark: Polycystic Ovary Syndrome

Patient basic information Patient: Mr. Mark King) Nationality: Suriname Diagnosis: Polycystic Ovary Syndrome Clinic: Hong Kong University Shenzhen Hospital Treatment: Stem Cell Transplant + Supporting Treatment Household days: 111 days Treatment cost: approximately 214,327 yuan Treatment effect: Functional recovery Description: Mr. Mark is from Suriname, where he was diagnosed with polycystic ovary syndrome.

After arriving at the Shenzhen Hospital of the University of Hong Kong, the International Medical Services team arranged for the first time multidisciplinary MDT for patients, developed individualized pathways based on the patient's examination reports and physical condition, and provided full translation, accompaniment and landing services. During the treatment process, the team of experts at the Shenzhen Hospital of the University of Hong Kong used a comprehensive set of stem cell transplants + supportive treatments, during which the medical team closely monitored the patient's indicators, dynamic adjustment programs. After 111 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the hospital standard.

Treatment results: Patient's final functional recovery. At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient, and continued to monitor the recovery through a remote follow-up system. 'Mr.

Liu Mark criticized this case as a typical case of cross-border suspected seriousness clinical disease. The University of Hong Kong Shenzhen Hospital, based on a multidisciplinary collaborative mechanism, developed a stem cell transplant + support treatment for polycystic ovary syndrome, which reflects the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and is a shorthand for the regulation of international visitor medical services.

苏里南,多囊卵巢综合征,香港大学深圳医院,国际医疗,来华就医,中国医疗